ストックスクリーナーアプリを入手
3.77
9.59%
-0.40
プレマーケット:
3.85
0.08
+2.12%
前日終値:
$4.17
開ける：
$4.16
24時間の取引高:
320.63K
Relative Volume:
0.17
時価総額：
$92.09M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-25.20%
1か月 パフォーマンス:
+27.80%
6か月 パフォーマンス:
+54.51%
1年 パフォーマンス:
-64.83%
1日の値動き範囲:
$3.75
$4.2449
1週間の範囲:
$3.75
$4.985
52週間の値動き範囲:
$1.47
$15.49
Artiva Biotherapeutics Inc Stock (ARTV) Company Profile
名前
Artiva Biotherapeutics Inc
セクター
電話
(858) 267-4467
住所
5505 MOREHOUSE DRIVE, SAN DIEGO
ARTV を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ARTV
Artiva Biotherapeutics Inc
|
3.77 | 101.86M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-11 | 再開されました | H.C. Wainwright | Buy |
| 2024-12-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-08-13 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-08-13 | 開始されました | Jefferies | Buy |
| 2024-08-13 | 開始されました | Needham | Buy |
| 2024-08-13 | 開始されました | TD Cowen | Buy |
| 2024-08-13 | 開始されました | Wedbush | Outperform |
すべてを表示
Artiva Biotherapeutics Inc (ARTV) 最新ニュース
Is Artiva Biotherapeutics Inc. stock attractive for retirement portfoliosInflation Watch & Weekly Stock Breakout Alerts - newser.com
Artiva Biotherapeutics Inc. stock daily chart insightsEarnings Summary Report & Free AI Powered Buy and Sell Recommendations - newser.com
Artiva Biotherapeutics to Host Webcast on Initial Safety and Translational Data for AlloNK in Autoimmune Disease Treatment - Quiver Quantitative
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK® - Yahoo Finance
Can Artiva Biotherapeutics Inc. stock resist sector downturnsPortfolio Risk Report & AI Driven Stock Movement Reports - newser.com
Relative strength of Artiva Biotherapeutics Inc. in sector analysis2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Is Artiva Biotherapeutics Inc. stock supported by strong cash flowsWeekly Trade Report & Community Consensus Picks - newser.com
Advanced analytics toolkit walkthrough for Artiva Biotherapeutics Inc.2025 Stock Rankings & Weekly Breakout Stock Alerts - newser.com
Why Artiva Biotherapeutics Inc. stock could rally in 2025Quarterly Portfolio Review & Verified Momentum Watchlists - newser.com
Why Artiva Biotherapeutics Inc. stock is popular among millennialsWeekly Market Summary & AI Enhanced Trading Signals - newser.com
How resilient is Artiva Biotherapeutics Inc. stock in market downturnsEarnings Recap Report & Fast Gain Stock Trading Tips - newser.com
Published on: 2025-11-03 03:05:55 - newser.com
What risks investors should watch in Artiva Biotherapeutics Inc. stockJobs Report & Long Hold Capital Preservation Plans - newser.com
Will Artiva Biotherapeutics Inc. stock beat EPS estimatesPortfolio Performance Report & Reliable Entry Point Trade Alerts - newser.com
Identifying reversal signals in Artiva Biotherapeutics Inc.July 2025 PreEarnings & Fast Gaining Stock Reports - newser.com
How to escape a deep drawdown in Artiva Biotherapeutics Inc.Oil Prices & Fast Entry and Exit Trade Plans - newser.com
Artiva Biotherapeutics Inc. stock volume spike explained2025 Top Decliners & Free Verified High Yield Trade Plans - newser.com
Published on: 2025-11-02 01:36:46 - newser.com
Published on: 2025-11-01 12:39:19 - newser.com
Published on: 2025-11-01 06:37:19 - newser.com
Best Small Cap Stocks To ConsiderOctober 19th - MarketBeat
Artiva Biotherapeutics (NASDAQ:ARTV) Given Sell (D-) Rating at Weiss Ratings - MarketBeat
Why analysts remain bullish on Artiva Biotherapeutics Inc. stockBull Run & Free Weekly Watchlist of Top Performers - newser.com
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November - GlobeNewswire
Artiva Bio Soaring on Focus Shift from Oncology to Autoimmune Disease - San Diego Business Journal
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Artiva Biotherapeutics Inc (ARTV) 財務データ
Artiva Biotherapeutics Inc (ARTV) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.64%
0.35%
大文字化:
|
ボリューム (24 時間):